COMPARING THE EFFICACY OF DRONEDARONE WITH OLDER ANTI-ARRHYTHMIC DRUGS IN PHARMACOLOGICAL ENHANCEMENT OF ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION

被引：0
|
作者：
Ajmal, Muhammad S.
Herle, Aravind
机构：
[1] Mercy Hosp, Buffalo, NY USA
[2] SUNY Buffalo, Catholic Hlth Syst Internal Med Residency Program, Buffalo, NY 14260 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)60689-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E688 / E688
页数：1
相关论文
共 50 条
  • [1] Anti-arrhythmic drugs before, during and after transvenous electrical cardioversion of atrial fibrillation in horses: Weighing the benefits and risks
    Decloedt, Annelies
    van Loon, Gunther
    EQUINE VETERINARY EDUCATION, 2024, 36 (04) : 176 - 180
  • [2] Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs
    Vinolas, Xavier
    Freire, Fernando
    Romero-Menor, Cesar
    Alegret, Josep M.
    MEDICINA CLINICA, 2013, 140 (08): : 351 - 355
  • [3] Most effective therapy for new intraoperative atrial fibrillation during thoracic operations: electrical cardioversion, not anti-arrhythmic drugs
    Wu, D. H.
    Xu, M. Y.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 67 - 67
  • [4] Novel anti-arrhythmic drugs for atrial fibrillation management
    Ehrlich, Joachim R.
    Nattel, Stanley
    Hohnloser, Stefan H.
    CURRENT VASCULAR PHARMACOLOGY, 2007, 5 (03) : 185 - 194
  • [5] PROFILES AND USE OF ANTI-ARRHYTHMIC DRUGS IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION FOR PERSISTENT ATRIAL FIBRILLATION-INSIGHTS FROM THE REALISEAF REGISTRY
    O'Neill, J.
    Chiang, C. -E.
    Gamra, H.
    Goethals, M.
    Inoue, H.
    Murin, J.
    Naditch-Brule, L.
    Ponikowski, P.
    Zharinov, O.
    Steg, G.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 : S97 - S98
  • [6] Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
    Savelieva, Irina
    Camm, John
    EUROPACE, 2008, 10 (06): : 647 - 665
  • [7] Anti-arrhythmic drugs confer increased risks of bradyarrhythmia in patients undergoing direct current cardioversion for atrial fibrillation
    Rasmussen, P., V
    Dalgaard, F.
    Pallisgaard, J. L.
    Gislason, G.
    Ruwald, M. H.
    Torp-Pedersen, C.
    Hansen, M. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 554 - 554
  • [8] Vernakalant Compared to Anti-arrhythmic Drugs for Rapid Cardioversion of Early Onset Atrial Fibrillation: A Meta-analysis
    Trivedi, Chintan G.
    Mohanty, Sanghamitra
    Della Rocca, Domenico Giovanni
    Gianni, Carola
    Di Biase, Luigi
    Natale, Andrea
    CIRCULATION, 2019, 140
  • [9] Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
    Capucci, Alessandro
    Stronati, Giulia
    Guerra, Federico
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : C12 - C14
  • [10] Anti-arrhythmic drugs in atrial fibrillation:: Historical perspectives and new developments
    Luederitz, Berndt
    CURRENT NEWS IN CARDIOLOGY, 2007, : 3 - 9
12345